ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627168 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627168; 2) Community: the network communities that were significantly associated with the response to NSC 627168; 3) Molecule: the relationships between components within communities and NSC 627168; 4) MDR: the compounds that were significantly associated with the NSC 627168.

NSC Compound Enrichment Correlation
NSC 671392 Null 0.0454469012959173 0.22042654
NSC 676372 Null 0.0454469012959173 0.015773733
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0454469012959173 0.45015025
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0454469012959173 0.54482727
NSC 67925 Null 0.0454469012959173 0.28672045
NSC 681239 Bortezomib 0.0454469012959173 -0.11396471
NSC 681636 Camptothecin Derivative 0.0454469012959173 0.24318842
NSC 681645 Camptothecin Derivative 0.0454469012959173 0.25179646
NSC 682763 Null 0.0454469012959173 0.049385361
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0454469012959173 0.37258492
Total:81  Current:78    [First] [Prev] [Next] [Last]